Methamphetamine use during pregnancy: Maternal and neonatal implications

Obstetrics and Gynecology

Volumn 116, Issue 2, 2010, Pages 330-334

  Good, Meadow M ^a   Solt, Ido ^a   Acuna, Joann G ^a   Rotmensch, Siegfried ^a   Kim, Matthew J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADOPTION; ADULT; ALCOHOL CONSUMPTION; APGAR SCORE; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DOMESTIC VIOLENCE; DRUG DEPENDENCE; ETHNICITY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MATERNAL SMOKING; NEWBORN; NEWBORN MORTALITY; PERINATAL MORBIDITY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNEMPLOYMENT;

ACADEMIC MEDICAL CENTERS; CALIFORNIA; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; METHAMPHETAMINE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION;

EID: 77955140282     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181e67094     Document Type: Article

References (32)

1. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction 2009;104:1085-99.
2. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 2008;29:31-49.
3. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000;32:137-41.
4. Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J 2006;10:293-302.
5. Marwick C. NIDA seeking data on effect of fetal exposure to methamphetamine. JAMA 2000;283:2225-6.
6. Salisbury AL, Ponder KL, Padbury JF, Lester BM. Fetal effects of psychoactive drugs. Clin Perinatol 2009;36:595-619.
7. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6.
8. Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol 2009;113:1285-91.
9. Wouldes T, LaGasse L, Sheridan J, Lester B. Maternal methamphetamine use during pregnancy and child outcome: what do we know? N Z Med J 2004;117:U1180.
10. Chomchai C, Na Manorom N, Watanarungsan P, Yossuck P, Chomchai S. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. SE Asian J Trop Med Public Health 2004;35:228-31.
11. Della Grotta S, Lagasse LL, Arria AM, Derauf C, Grant P, Smith LM, et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 2009 Jun 30 [Epub ahead of print].
12. Perez JA Jr, Arsura EL, Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med 1999;17:469-71.
13. Jeng W, Wong AW, Ting-A-Kee R, Wells PG. Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 2005;39:317-26.
14. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987;111:571-8.
15. Catanzarite VA, Stein DA. ‘Crystal’ and pregnancy—methamphetamine-associated maternal deaths. West J Med 1995;162:454-7.
16. Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 1997;21:515-7.
17. Slamberova R, Charousova P, Pometlova M. Maternal behavior is impaired by methamphetamine administered during pre-mating, gestation and lactation. Reprod Toxicol 2005;20:103-10.
18. Slamberova R, Charousova P, Pometlova M. Methamphetamine administration during gestation impairs maternal behavior. Dev Psychobiol 2005;46:57-65.
19. Scutari C. Two plans tackle meth in Arizona. The Arizona Republic February 14, 2006. Available at: .Retrieved June 8, 2010.
20. Ganapathy VV, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Druv Deliv Rev 1999;38:99-110.
21. Bartu A, Dusci LJ, Ilett KF. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 2009;67:455-9.
22. Stek AM, Baker RS, Fisher BK, Lang U, Tseng CY, Clark KE. Maternal and fetal cardiovascular responses to methamphetamine in the pregnant sheep. Am J Obstet Gynecol 1993;169:888-97.
23. Stek AM, Baker RS, Fisher BK, Lang U, Clark KE. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol 1995;173:1592-8.
24. Won L, Bubula N, McCoy H, Heller A. Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. Neurotoxicol Teratol 2001;23:349-54.
25. Inoue H, Nakatome M, Terada M, Mizuno M, Ono R, Iino M, et al. Maternal methamphetamine administration during pregnancy influences on fetal rat heart development [corrected]. Life Sci 2004;74:1529-40.
26. Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004;132:95-106.
27. Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S, et al. Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 2009;48:391-7.
28. Little BB, Snell LM, Gilstrap LC 3rd. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988;72:541-4.
29. Elliott L, Loomis D, Lottritz L, Slotnick RN, Oki E, Todd R. Case-control study of a gastroschisis cluster in Nevada. Arch Pediatr Adolesc Med 2009;163:1000-6.
30. Lu LH, Johnson A, O'Hare ED, Bookheimer SY, Smith LM, O'Connor MJ, et al. Effects of prenatal methamphetamine exposure on verbal memory revealed with functional magnetic resonance imaging. J Dev Behav Pediatr 2009;30:185-92.
31. Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Ped 2003;24:17-23.
32. Shindelman J, Mahal J, Hemphill G, Pizzo P, Coty WA. Development and evaluation of an improved method for screening of amphetamines. J Anal Toxicol 1999;23:506-10.